Synthesis and Structure−Activity Relationship Study of Isoglobotrihexosylceramide Analogues
- 17 November 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 72 (26) , 9914-9923
- https://doi.org/10.1021/jo701539k
Abstract
Invariant natural killer T (iNKT) cells are innate T lymphocytes that express T cell receptors binding to exogenous and endogenous glycosphingolpid antigens presented by a nonpolymorphic, non-MHC antigen presenting molecule, CD1d. The endogenous glycosphingolipid metabolite, isoglobotrihexosylceramide (iGb3), is the first known natural ligand for both human and mouse iNKT cells, whose activity has been confirmed in a variety of iNKT cell clones generated by different investigators, representing the majority of the iNKT cell population. The signaling pathway mediated by T cell receptor is largely influenced by the structural variation of glycosphingolpid antigens, leading to multiple and varied biological functions of iNKT cells. In order to investigate the structural requirements behind iGb3 triggered iNKT cell activation, the structure-activity relationship (SAR) of iGb3 needs to be characterized. In this study, iGb3 analogues containing 2' '', 3' '', 4' '' and 6' '' deoxy terminal galactose were synthesized for probing the SAR between iGb3 and TCR. The biological assays on the synthetic iGb3 analogues were performed with use of the murine iNKT cell hybridoma DN32.D3. The results showed that the 2' '' and 3' '' hydroxyl groups of terminal galactose play more important roles for the recognition of iGb3 by TCR; while 4' '' and 6' '' hydroxyl groups were not as crucial for this recognition. These studies might help to understand the general structural requirements for natural endogenous ligands recognized by iNKT cells.Keywords
This publication has 24 references indexed in Scilit:
- Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammalsProceedings of the National Academy of Sciences, 2007
- The crystal structure of human CD1d with and without α-galactosylceramideNature Immunology, 2005
- Structure and function of a potent agonist for the semi-invariant natural killer T cell receptorNature Immunology, 2005
- Crystal Structure of a Photolyase Bound to a CPD-Like DNA Lesion After in Situ RepairScience, 2004
- Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Vα14 NKT cellsInternational Immunology, 2001
- The Immunological SynapseAnnual Review of Immunology, 2001
- Recognition and function of Vα14 NKT cellsSeminars in Immunology, 2000
- Functional Natural Killer T Cells in Experimental Mouse Strains, Including NK1.1- Strains.Experimental Animals, 2000
- CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by GlycosylceramidesScience, 1997
- Structure-Activity Relationship of .alpha.-Galactosylceramides against B16-Bearing MiceJournal of Medicinal Chemistry, 1995